Garuda - Garba Rujukan Digital

Frilya Rachma Putri

Departemen Psikiatri, Fakultas Kedokteran, Universitas Brawijaya – RSUD Dr. Saiful Anwar

Author-ID : 5593383

Humanities Education Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document

Claim Missing Document

Articles

ORAL ARIPIPRAZOLE FOR THE TREATMENT OF TOURETTE'S SYNDROME IN CHILDREN Frilya Rachma Putri; Mayniar Ayu Rahmadianti
Journal of Psychiatry Psychology and Behavioral Research Vol. 1 No. 2 (2020)
Publisher : Departemen Psikiatri Fakultas Kedokteran Universitas Brawijaya

BackgroundÂ Â Â Â Â Â Â Â Â Â Among the pharmacotherapy recommendations for Tourette syndrome (TS), Aripiprazole is a potential treatment option for TS and a relatively safe alternative in the pediatric population.Â Case presentationWe report the case of a pediatric patient with TS who was admitted to the hospital after demonstrating severe involuntary movements. The symptoms emerged early in childhood and remained subclinical. It became more noticeable at 3 months before admission when the frequency and the severity started to increase progressively reaching its peak at one month before hospitalization. From further assessment, we found speech delay and a notably high score of Strength and Difficulties Questionnaire (SDQ)At the time of hospitalization, the symptom relieved following the admission of Aripiprazole 1 x 2 mg. It significantly diminished to infrequent minor facial tics. There was no adverse effect reported upon hospital discharge. We also performed family psychoeducation and speech therapy as adjuvant therapy.ConclusionsWe selected Aripiprazole because of its unique mechanism of action resulted in a dopamine stabilizer feature with less side effect. The most common ones are nausea, sedation, and increased appetite where, generally, are lessen within 2 weeks. Moreover, in contrast with other antipsychotics, Aripiprazole would not provoke hyperprolactinemia. The more severe side effect such as extrapyramidal symptoms and weight gain are usually dose-dependent at around 10 mg/day. Aripiprazole is also favourable, especially for refractory cases.

ADHD WITH NON-ORGANIC ENURESIS AND BORDERLINE INTELLIGENT QUOTIENT Frilya Rachma Putri; Herman Yosef
Journal of Psychiatry Psychology and Behavioral Research Vol. 2 No. 1 (2021)
Publisher : Departemen Psikiatri Fakultas Kedokteran Universitas Brawijaya

Symptoms of Attention Deficit Hyperacitivity Disorder (ADHD) can be associated with nocturnal enuresis. Nocturnal enuresis cases are common occur in children with Mental Retardation. There are several hypotheses underlying this comorbidity, such as genetic, neurophysiological, environmental and psychosocial factors. We report the case of a 7 year old boy with symptoms such as inability to concentrate, active movement, talk a lot, unable to wait his turn, unable to delay desires, easy fighting and behaving and speaking harshly. Patients still wet the bed at night at least 3-4 times a week The Abbreviated Conners Score rating scale assessed by the mother at the start of treatment was 21. The IQ test score was 71 and the Strength and Difficulty Questionnaire (SDQ) score was 35. The patient's symptoms were reduced after 4-month therapy with 2x5mg of methylphenidate administration, psychoeducation of parents to implement toilet training and behavior therapy for patients, apply reward and punishment with the principle of token economy. In the development process of children and adolescents, parenting is an important factor. Many studies shows that parenting can impact the resilience and vulnerability of a child to behavioral disorders. In children with ADHD with borderline IQ and enuresis, parenting with a high parental control component can cause psychological symptoms to worsen without being balanced with the attitude of parents who are responsive to the psychological needs of the child.

Title

Found 2 Documents
Search

Abstract

Abstract

Title Search

Found 2 Documents Search

Abstract

Abstract

Title

Found 2 Documents
Search